Advanced glycation end products and neurodegenerative diseases: Mechanisms and perspective

Journal of the Neurological Sciences

Volumn 317, Issue 1-2, 2012, Pages 1-5

  Li, Jinlong ^a   Liu, Danian ^a   Sun, Ling ^a   Lu, Yunting ^a   Zhang, Zhongling ^a  

^a THE FIRST AFFILIATED HOSPITAL OF HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

Synuclein; Advanced glycation end products; Amyloid ; Neurodegenerative diseases; Neurotoxicity; Tau

Indexed keywords

ADVANCED GLYCATION END PRODUCT; GLUCOSE;

ALZHEIMER DISEASE; CHEMICAL STRUCTURE; CLINICAL FEATURE; DEGENERATIVE DISEASE; HISTOCHEMISTRY; INFLAMMATION; NEUROTOXICITY; OXIDATIVE STRESS; PARKINSON DISEASE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN GLYCOSYLATION; PROTEIN MODIFICATION; REVIEW; SIGNAL TRANSDUCTION;

ALZHEIMER DISEASE; ANIMALS; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; NEURODEGENERATIVE DISEASES; PARKINSON DISEASE; SIGNAL TRANSDUCTION;

EID: 84862780458     PISSN: 0022510X     EISSN: 18785883     Source Type: Journal    
DOI: 10.1016/j.jns.2012.02.018     Document Type: Review

References (50)

1. A. Yamamoto, and A. Simonsen The elimination of accumulated and aggregated proteins: a role for aggrephagy in neurodegeneration Neurobiol Dis 43 2011 17 28
2. V. Calabrese, C. Cornelius, C. Mancuso, R. Lentile, A.M. Stella, and D.A. Butterfield Redox homeostasis and cellular stress response in aging and neurodegeneration Methods Mol Biol 610 2010 285 308
3. F.E. Samson, and S.R. Nelson The aging brain, metals and oxygen free radicals Cell Mol Biol (Noisy-le-Grand) 46 2000 699 707
4. J.B. Schulz, J. Lindenau, J. Seyfried, and J. Dichgans Glutathione, oxidative stress and neurodegeneration Eur J Biochem 267 2000 4904 4911 (Pubitemid 30641286)
5. M.H. Vicente, and T.F. Outeiro The sour side of neurodegenerative disorders: the effects of protein glycation J Pathol 221 2010 13 25
6. V. Srikanth, A. Maczurek, T. Phan, M. Steele, B. Westcott, and D. Juskiw Advanced glycation endproducts and their receptor RAGE in Alzheimer's disease Neurobiol Aging 32 2011 763 777
7. M.A. Grillo, and S. Colombatto Advanced glycation end-products (AGEs): involvement in aging and in neurodegenerative diseases Amino Acids 35 2008 29 36
8. J.P. Richard Mechanism for the formation of methylglyoxal from triosephosphates Biochem Soc Trans 21 1993 549 553 (Pubitemid 23167966)
9. P.J. Thornalley Pharmacology of methylglyoxal: formation, modification of proteins and nucleic acids, and enzymatic detoxification - a role in pathogenesis and antiproliferative chemotherapy Gen Pharmacol 27 1996 565 573 (Pubitemid 26233322)
10. T. Chang, and L. Wu Methylglyoxal, oxidative stress, and hypertension Can J Physiol Pharmacol 84 2006 1229 1238 (Pubitemid 46707370)
11. P.J. Thornalley Methylglyoxal, glyoxalases and the development of diabetic complications Amino Acids 6 1994 15 23 (Pubitemid 24068119)
12. P. Thornalley, S. Wolff, J. Crabbe, and A. Stern The autoxidation of glyceraldehyde and other simple monosaccharides under physiological conditions catalysed by buffer ions Biochim Biophys Acta 797 1984 276 287 (Pubitemid 14197639)
13. P.J. Thornalley Glutathione-dependent detoxification of alpha-oxoaldehydes by the glyoxalase system: involvement in disease mechanisms and antiproliferative activity of glyoxalase I inhibitors Chem Biol Interact 111-112 1998 137 151 (Pubitemid 28271940)
14. T. Niwa 3-Deoxyglucosone: metabolism, analysis, biological activity, and clinical implication J Chromatogr B Biomed Sci Appl 731 1999 23 36 (Pubitemid 29376410)
15. P. Alexiou, M. Chatzopoulou, K. Pegklidou, and V.J. Demopoulos RAGE: a multi-ligand receptor unveiling novel insights in health and disease Curr Med Chem 17 2010 2232 2252
16. M. Neeper, A.M. Schmidt, J. Brett, S.D. Yan, F. Wang, and Y.C. Pan Cloning and expression of a cell surface receptor for advanced glycosylation end products of proteins J Biol Chem 267 1992 14998 15004
17. G. Srikrishna, H.J. Huttunen, L. Johansson, B. Weigle, Y. Yamaguchi, and H. Rauvala N-Glycans on the receptor for advanced glycation end products influence amphoterin binding and neurite outgrowth J Neurochem 80 2002 998 1008 (Pubitemid 34809952)
18. L. Zhang, R. Postina, and Y. Wang Ectodomain shedding of the receptor for advanced glycation end products: a novel therapeutic target for Alzheimer's disease Cell Mol Life Sci 66 2009 3923 3935
19. A. Bierhaus, P.M. Humpert, M. Morcos, T. Wendt, T. Chavakis, and B. Arnold Understanding RAGE, the receptor for advanced glycation end products J Mol Med (Berl) 83 2005 876 886 (Pubitemid 41598688)
20. J. Li, and A.M. Schmidt Characterization and functional analysis of the promoter of RAGE, the receptor for advanced glycation end products J Biol Chem 272 1997 16498 16506 (Pubitemid 27276477)
21. H.J. Cho, S.M. Son, S.M. Jin, H.S. Hong, D.H. Shin, and S.J. Kim RAGE regulates BACE1 and Abeta generation via NFAT1 activation in Alzheimer's disease animal model FASEB J 23 2009 2639 2649
22. S.W. Kim, C.M. Lim, J.B. Kim, J.H. Shin, S. Lee, and M. Lee Extracellular HMGB1 released by NMDA treatment confers neuronal apoptosis via RAGE-p38 MAPK/ERK signaling pathway Neurotox Res 20 2011 159 169
23. H.J. Huttunen, J. Kuja-Panula, and H. Rauvala Receptor for advanced glycation end products (RAGE) signaling induces CREB-dependent chromogranin expression during neuronal differentiation J Biol Chem 277 2002 38635 38646 (Pubitemid 35154724)
24. Y. Xu, F. Toure, W. Qu, L. Lin, F. Song, and X. Shen Advanced glycation end product (AGE)-receptor for AGE (RAGE) signaling and up-regulation of Egr-1 in hypoxic macrophages J Biol Chem 285 2010 23233 23240
25. B.I. Hudson, A.Z. Kalea, M.A.M. Del, E. Harja, E. Boulanger, and V. D'Agati Interaction of the RAGE cytoplasmic domain with diaphanous-1 is required for ligand-stimulated cellular migration through activation of Rac1 and Cdc42 J Biol Chem 283 2008 34457 34468
26. R.E. Tanzi A genetic dichotomy model for the inheritance of Alzheimer's disease and common age-related disorders J Clin Invest 104 1999 1175 1179 (Pubitemid 29536288)
27. S. Gandy The role of cerebral amyloid beta accumulation in common forms of Alzheimer disease J Clin Invest 115 2005 1121 1129 (Pubitemid 40629026)
28. J.J. Li, D. Voisin, A.L. Quiquerez, and C. Bouras Differential expression of advanced glycosylation end-products in neurons of different species Brain Res 641 1994 285 288 (Pubitemid 24101296)
29. G. Munch, S. Mayer, J. Michaelis, A.R. Hipkiss, P. Riederer, and R. Muller Influence of advanced glycation end-products and AGE-inhibitors on nucleation-dependent polymerization of beta-amyloid peptide Biochim Biophys Acta 1360 1997 17 29 (Pubitemid 27083656)
30. S.Y. Ko, Y.P. Lin, Y.S. Lin, and S.S. Chang Advanced glycation end products enhance amyloid precursor protein expression by inducing reactive oxygen species Free Radic Biol Med 49 2010 474 480
31. H.M. Schipper Apolipoprotein E: implications for AD neurobiology, epidemiology and risk assessment Neurobiol Aging 32 2011 778 790
32. Y.M. Li, and D.W. Dickson Enhanced binding of advanced glycation endproducts (AGE) by the ApoE4 isoform links the mechanism of plaque deposition in Alzheimer's disease Neurosci Lett 226 1997 155 158 (Pubitemid 27201967)
33. M.D. Ledesma, P. Bonay, and J. Avila Tau protein from Alzheimer's disease patients is glycated at its tubulin-binding domain J Neurochem 65 1995 1658 1664
34. X.H. Li, B.L. Lv, J.Z. Xie, J. Liu, X.W. Zhou, and J.Z. Wang AGEs induce Alzheimer-like tau pathology and memory deficit via RAGE-mediated GSK-3 activation Neurobiol Aging 2011 [Electronic publication ahead of print]
35. A.J. Lees, J. Hardy, and T. Revesz Parkinson's disease Lancet 373 2009 2055 2066
36. L.S. Forno Neuropathology of Parkinson's disease J Neuropathol Exp Neurol 55 1996 259 272 (Pubitemid 26085575)
37. H. Braak, T.K. Del, U. Rub, R.A. de Vos, S.E.N. Jansen, and E. Braak Staging of brain pathology related to sporadic Parkinson's disease Neurobiol Aging 24 2003 197 211 (Pubitemid 36007810)
38. T.F. Outeiro, E. Kontopoulos, S.M. Altmann, I. Kufareva, K.E. Strathearn, and A.M. Amore Sirtuin 2 inhibitors rescue alpha-synuclein-mediated toxicity in models of Parkinson's disease Science 317 2007 516 519 (Pubitemid 47196116)
39. D. Lee, C.W. Park, S.R. Paik, and K.Y. Choi The modification of alpha-synuclein by dicarbonyl compounds inhibits its fibril-forming process Biochim Biophys Acta 1794 2009 421 430
40. V. Padmaraju, J.J. Bhaskar, R.U.J. Prasada, P.V. Salimath, and K.S. Rao Role of advanced glycation on aggregation and DNA binding properties of alpha-synuclein J Alzheimers Dis 24 Suppl 2 2011 211 221
41. L. Chen, Y. Wei, X. Wang, and R. He Ribosylation rapidly induces alpha-synuclein to form highly cytotoxic molten globules of advanced glycation end products PLoS One 5 2010 e9052
42. E. Dalfo, M. Portero-Otin, V. Ayala, A. Martinez, R. Pamplona, and I. Ferrer Evidence of oxidative stress in the neocortex in incidental Lewy body disease J Neuropathol Exp Neurol 64 2005 816 830 (Pubitemid 41285815)
43. R. Castellani, M.A. Smith, P.L. Richey, and G. Perry Glycoxidation and oxidative stress in Parkinson disease and diffuse Lewy body disease Brain Res 737 1996 195 200 (Pubitemid 26366614)
44. E. Kaufmann, B.O. Boehm, S.D. Sussmuth, R. Kientsch-Engel, A. Sperfeld, and A.C. Ludolph The advanced glycation end-product N epsilon-(carboxymethyl) lysine level is elevated in cerebrospinal fluid of patients with amyotrophic lateral sclerosis Neurosci Lett 371 2004 226 229 (Pubitemid 39440776)
45. R. Gomes, S.M. Sousa, A. Quintas, C. Cordeiro, A. Freire, and P. Pereira Argpyrimidine, a methylglyoxal-derived advanced glycation end-product in familial amyloidotic polyneuropathy Biochem J 385 2005 339 345 (Pubitemid 40165065)
46. N. Sasaki, M. Takeuchi, H. Chowei, S. Kikuchi, Y. Hayashi, and N. Nakano Advanced glycation end products (AGE) and their receptor (RAGE) in the brain of patients with Creutzfeldt-Jakob disease with prion plaques Neurosci Lett 326 2002 117 120 (Pubitemid 34607573)
47. S. Anzilotti, C. Giampa, D. Laurenti, L. Perrone, G. Bernardi, and M.A. Melone Immunohistochemical localization of receptor for advanced glycation end (RAGE) products in the R6/2 mouse model of Huntington's disease Brain Res Bull 87 2011 350 358
48. G. Li, M. Chang, H. Jiang, H. Xie, Z. Dong, and L. Hu Proteomics analysis of methylglyoxal-induced neurotoxic effects in SH-SY5Y cells Cell Biochem Funct 29 2011 30 35
49. J.W. Nin, A. Jorsal, I. Ferreira, C.G. Schalkwijk, M.H. Prins, and H.H. Parving Higher plasma levels of advanced glycation end products are associated with incident cardiovascular disease and all-cause mortality in type 1 diabetes: a 12-year follow-up study Diabetes Care 34 2011 442 447
50. A. Rahmadi, N. Steiner, and G. Munch Advanced glycation endproducts as gerontotoxins and biomarkers for carbonyl-based degenerative processes in Alzheimer's disease Clin Chem Lab Med 49 2011 385 391